Ted Yednock - Jun 3, 2021 Form 4 Insider Report for Annexon, Inc. (ANNX)

Role
EVP & Chief Scientific Officer
Signature
/s/ Jennifer Lew, as Attorney-in-Fact for Ted Yednock
Stock symbol
ANNX
Transactions as of
Jun 3, 2021
Transactions value $
-$301,181
Form type
4
Date filed
6/7/2021, 04:47 PM
Next filing
Sep 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANNX Common Stock Options Exercise $21.1K +15K $1.41 15K Jun 3, 2021 Direct
transaction ANNX Common Stock Sale -$275K -12.8K -85.44% $21.45* 2.18K Jun 3, 2021 Direct F1, F2
transaction ANNX Common Stock Sale -$47.4K -2.18K -100% $21.72* 0 Jun 3, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANNX Stock Option (Right to Buy) Options Exercise $0 -15K -36.93% $0.00 25.6K Jun 3, 2021 Common Stock 15K $1.41 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades in prices ranging from $20.67 to $21.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 This transaction was executed in multiple trades in prices ranging from $21.665 to $21.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The shares subject to the option vest are fully vested and exercisable.